Infantile Neuronal Ceroid Lipofuscinosis Type 2

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2019-12-06
FDA Approved: BRINEURA — Supplemental Application (BioMarin Pharmaceutical Inc.)
The FDA approved a supplemental application for BRINEURA (cerliponase alfa) submitted by BioMarin Pharmaceutical Inc. for use in CLN2 diseas…